: Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM

Clinical Trial ID NCT04492163

Rank	Title	Journal	Year	PubWeight™‹?›
1	Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.	J Clin Oncol	2010	14.79
2	NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.	Eur J Cancer	2012	3.66
3	Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.	Proc Natl Acad Sci U S A	2007	2.64
4	Disruption of cancer cell replication by alternating electric fields.	Cancer Res	2004	2.62
5	Alternating electric fields (TTFields) inhibit metastatic spread of solid tumors to the lungs.	Clin Exp Metastasis	2009	1.15
6	Tumor treating fields: concept, evidence and future.	Expert Opin Investig Drugs	2011	0.99
7	Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells.	Sci Rep	2015	0.93
8	Tumor Treating Fields: A Fourth Modality in Cancer Treatment.	Clin Cancer Res	2017	0.75